A newborn with homozygous a-thalassemia presented with intrauterine growth retardation and presumed persistent pulmonary hypertension. He also had moderate anemia, hepatomegaly and hypospadias. Correlating the newborn's clinical presentation with an underlying cause of anemia was helpful for early diagnosis. Prenatal blood tests must include red cell indices and a mean corpuscular volume value below 80 fL should prompt thalassemia screening in an at-risk population.
Case
Madam Y was a Chinese lady in her third pregnancy. Her ultrasound scans at the 14th, 18th and 22nd week of gestation showed no structural abnormalities in the fetus. Mild polyhydramnios was noted at 18 weeks. Liquor volume and fetal biometry parameters were normal at 22 weeks. However, at 35 weeks, she was referred for elective cesarean section as the fetus had developed severe intrauterine growth retardation with oligohydramnios. At birth, the baby was immediately intubated and ventilated. Apgar scores were 5 at 1 min and 6 at 5 min of life. He was mildly pale with a large liver measuring 6 cm below the right costal margin. He was not hydropic. His birth weight was 1991 g (below the third centile), which corresponded with his length and head circumference percentiles. He had penile hypospadias and bilaterally undescended testes. The placenta weighed 900 g.
The baby received aggressive intervention for cardiorespiratory support. There was clinical evidence of persistent pulmonary hypertension. An arterial blood sample at 1 h of life showed severe metabolic acidosis with a pH of 6.89, base excess of -22, PaO 2 of 15 mm Hg, and PaCO 2 of 54 mm Hg. Blood volume expansion was given. He was treated with inotropes and magnesium sulfate infusions, 20 ml kg À1 normal saline, repeated infusions of 4.2% sodium bicarbonate and empiric antibiotics.
The baby's hemoglobin at 2 h of life was 11.8 g per 100 ml. The peripheral blood film showed anisopoikilocytosis with numerous nucleated red blood cells (1489 per 100 white blood cells), target cells and Howell Jolly bodies. The cause of anemia 1 and low oxygen carrying capacity of the blood was suspected to be a severe hemoglobinopathy although his parents were not known thalassemia carriers.
At 5 h of life, a transfusion of 10 ml kg À1 packed red cells improved the partial pressure of oxygen and the metabolic acidosis. Subsequently, a partial exchange transfusion with 50 ml kg À1 of packed cells was performed to correct anemia in the presence of heart failure. At 17 h of life, the baby developed pulmonary hemorrhage secondary to disseminated intravascular coagulopathy.
At 26 h of life, the hemoglobin electrophoresis of the baby's blood confirmed the diagnosis of Bart's hemoglobinopathy. Only Hemoglobin Bart's, hemoglobin H and embryonic hemoglobin were present. Fetal hemoglobin and adult hemoglobin were absent. Molecular genotyping revealed that the newborn was homozygous for --SEA a-thalassemia mutation with absence of all four a-globin genes. Both parents were confirmed carriers of the --SEA deletion (Table 1) . After counseling about incompatibility of the diagnosis with long-term survival, parents agreed for withdrawal of therapy and the baby died shortly after.
Discussion
This is a newborn with atypical features of homozygous a-thalassemia which posed a diagnostic challenge. The baby's unstable cardiorespiratory status drew attention away from his other presenting features of anemia and hepatomegaly. The absence of hydrops (peripheral edema, ascites, pleural effusions) diverted us from the diagnosis of homozygous a-1 thalassemia commonly known as Bart's hydrops fetalis 2,3 although cases of non-hydropic Bart's have been reported. 4, 5 The presence of numerous nucleated red blood cells and anisopoikilocytes was suggestive of markedly abnormal hemoglobinizationFthe hallmark of thalassemia.
There were several clues if clinical features are closely re-examined. First, the severe metabolic acidosis was unusual. A hemoglobin concentration of 11.8 g per 100 ml is not sufficiently low to produce anaerobic metabolism. Retrospectively, this was due to ineffective oxygen delivery to the cells. The 'effective' hemoglobin consisted only of embryonic hemoglobins (10-20% of the total hemoglobin concentration), 6 while Hemoglobin Bart's did not contribute to oxygen delivery to the tissues due to its high oxygen affinity. This was reflected by the discordant PaO 2 and SpO 2 values: PaO 2 was only 15 mm Hg when SpO 2 measured 85%. Thus, the pulse oximetry was not able to assess tissue oxygenation in the presence of the high Hemoglobin Bart's level and was falsely reassuring. In normal situations, pulse oximetry levels are calculated by the proportion of oxyhemoglobin and deoxyhemoglobin of adult hemoglobin. However, as fetal hemoglobin has similar absorbance properties to adult hemoglobin, it does not affect these calculations. 7, 8 Hypospadias has also been previously reported in newborns with homozygous a-thalassemia. 9, 10 It is interesting to postulate why the mother had oligohydramnios instead of polyhydramnios as classically described in pregnancies with Bart's hydrops fetalis. In pregnant ewes, oligohydramnios may be caused by increased intramembranous reabsorption of amniotic fluid secondary to chronic hypoxemia. 11 Madam Y fortunately did not have other associated complications, such as toxemia of pregnancy or post-partum hemorrhage. The pregnancy was not suspected to be at high risk for Bart's hydrops as her hemoglobin was normal. Adult carriers of a-1 thalassemia mutations are not significantly anemic, confirmed by the parents'post-partum blood count results in Table 1 . Thus, we suggest that prenatal maternal red cells indices should be routinely performed and in the presence of microcytosis (mean corpuscular volume < 80 fL) and/or hypochromia (MCH<27 pg) there should be further thalassemia screening of the couple. 5, 12, 13 The prevalence of --SEA deletion carriers in Southeast Asia ranges from 4.5% in Hong Kong to 14.0% in Northern Thailand. 14 Molecular genetics detected a 6.4% carrier frequency of a-thalassemia mutations from unselected cord blood samples in Singaporean Chinese. 15 With increasing globalization, unexpected cases of homozygous a-thalassemia in people of Southeast Asian descent may occur worldwide. 5, 16 Obstetricians and neonatologists worldwide thus need to be vigilant for the protean manifestations of the 'non-hydropic' Bart's fetus and newborn. Surely, the discordance of the arterial oxygen saturation and oxygen partial pressure and the presence of hypospadias should be a 'red flag'. Abbreviations: MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin.
